Ten-day sequential versus triple therapy for Helicobacterpylori eradication: A prospective, open-label, randomized trial

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 11, 2012, Pages 1675-1680

  Chung, Jun Won ^a   Jung, Young Kul ^a   Kim, Yoon Jae ^a   Kwon, Kwang Ahn ^a   Kim, Jung Ho ^a   Lee, Jong Joon ^a   Lee, Sung Min ^a   Hahm, Ki Baik ^a   Lee, Sun Mi ^b   Jeong, Jin Yong ^b   Yun, Sung Cheol ^b  

^a Gachon University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Antibiotics resistance; Clarithromycin; Helicobacter pylori; Metronidazole; Peptic ulcer disease

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; LEVOFLOXACIN; METRONIDAZOLE; TETRACYCLINE;

ABDOMINAL PAIN; ADULT; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ARTICLE; ASTHENIA; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; DISEASE CONTROL; DRUG WITHDRAWAL; DUODENUM ULCER; FEMALE; HEADACHE; HELICOBACTER INFECTION; HUMAN; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; KOREA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NONHUMAN; OPEN STUDY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; STOMACH ULCER; TASTE DISORDER; TREATMENT DURATION; UREA BREATH TEST;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BREATH TESTS; CHI-SQUARE DISTRIBUTION; CLARITHROMYCIN; CONFIDENCE INTERVALS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; METRONIDAZOLE; MIDDLE AGED; PATIENT COMPLIANCE; REPUBLIC OF KOREA; UREA;

EID: 84868124449     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07249.x     Document Type: Article

References (35)

1. Hentschel E, Brandstatter G, Dragosics B etal. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N. Engl. J. Med. 1993; 328: 308-312.
2. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol. 2007; 102: 1808-1825.
3. Malfertheiner P, Megraud F, O'Morain C etal. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-781.
4. Fock KM, Katelaris P, Sugano K etal. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J. Gastroenterol. Hepatol. 2009; 24: 1587-1600.
5. Chung JW, Lee GH, Han JH etal. The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea. Hepatogastroenterology 2011; 58: 246-250.
6. Kim BG, Lee DH, Ye BD etal. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea. Helicobacter 2007; 12: 31-35.
7. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 2007; 56: 1353-1357.
8. Gatta L, Vakil N, Leandro G, Di Mario F, Vaira D. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am. J. Gastroenterol. 2009; 104: 3069-3079; quiz 1080.
9. Jafri NS, Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann. Intern. Med. 2008; 148: 923-931.
10. Greenberg ER, Anderson GL, Morgan DR etal. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet 2011; 378: 507-514.
11. Kim YS, Kim SJ, Yoon JH etal. Randomised clinical trial: the efficacy of a 10-day sequential therapy versus a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment. Pharmacol. Ther. 2011; 34: 1098-1105.
12. Park HG, Jung MK, Jung JT etal. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naive patients. Aliment. Pharmacol. Ther. 2012; 35: 56-65.
13. Choi WH, Park DI, Oh SJ etal. [Effectiveness of 10day-sequential therapy for Helicobacter pylori eradication in Korea]. Korean J. Gastroenterol. 2008; 51: 280-284. (In Korean.)
14. Oh HS, Lee DH, Seo JY etal. Ten-day sequential therapy is more effective than proton pump inhibitor-basde therapy in Korea: a prospective, randomized study. J. Gastroenterol. Hepatol. 2012; 27: 504-509.
15. Vaira D, Zullo A, Vakil N etal. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann. Intern. Med. 2007; 146: 556-563.
16. Zullo A, Vaira D, Vakil N etal. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment. Pharmacol. Ther. 2003; 17: 719-726.
17. Sirimontaporn N, Thong-Ngam D, Tumwasorn S, Mahachai V. Ten-day sequential therapy of Helicobacter pylori infection in Thailand. Am. J. Gastroenterol. 2010; 105: 1071-1075.
18. Working Party of the European Helicobacter pylori Study Group. Technical annex: tests used to assess Helicobater pylori infection. Gut 1997; 41: S10-18.
19. Graham DY, Lu H, Yamaoka Y. A report card to grade Helicobacter pylori therapy. Helicobacter 2007; 12: 275-278.
20. Sanchez-Delgado J, Calvet X, Bujanda L, Gisbert JP, Tito L, Castro M. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. Am. J. Gastroenterol. 2008; 103: 2220-2223.
21. Vaira D, Zullo A, Hassan C, Fiorini G, Vakil N. Sequential therapy for Helicobacter pylori eradication: the time is now! Therap. Adv. Gastroenterol. 2009; 2: 317-322.
22. Romano M, Cuomo A, Gravina AG etal. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut 2010; 59: 1465-1470.
23. Kim JM, Kim JS, Jung HC, Kim N, Kim YJ, Song IS. Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea. Antimicrob. Agents Chemother. 2004; 48: 4843-4847.
24. Chung JW, Lee GH, Jeong JY etal. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance. J. Gastroenterol. Hepatol. 2012; 27: 493-497.
25. Nishizawa T, Suzuki H, Kurabayashi K etal. Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan. Antimicrob. Agents Chemother. 2006; 50: 1538-1540.
26. Matsuzaki J, Suzuki H, Nishizawa T etal. Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies. Antimicrob. Agents Chemother. 2012; 56: 1643-1645.
27. Matsuzaki J, Suzuki H, Tsugawa H, Nishizawa T, Hibi T. Homology model of the DNA gyrase enzyme of Helicobacter pylori, a target of quinolone-based eradication therapy. J. Gastroenterol. Hepatol. 2010; 25 (Suppl. 1): S7-10.
28. Suzuki H, Nishizawa T, Muraoka H, Hibi T. Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacterpylori with gyrA mutation. Antimicrob. Agents Chemother. 2009; 53: 1720-1721.
29. Cetinkaya ZA, Sezikli M, Guzelbulut F, Cosgun S, Duzgun S, Kurdas OO. Comparison of the efficacy of the two tetracycline-containing sequential therapy regimens for the eradication of Helicobacter pylori: 5days versus 14days amoxicillin. Helicobacter 2010; 15: 143-147.
30. Sezgin O, Altintas E, Nayir E, Ucbilek E. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey. Helicobacter 2007; 12: 629-632.
31. Katelaris PH, Forbes GM, Talley NJ, Crotty B. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the QUADRATE Study. Gastroenterology 2002; 123: 1763-1769.
32. Malfertheiner P, Bazzoli F, Delchier JC etal. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Lancet 2011; 377: 905-913.
33. Wu DC, Hsu PI, Wu JY etal. Sequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infection. Clin. Gastroenterol. Hepatol. 2010; 8: 36-41 e1.
34. Hsu PI, Wu DC, Wu JY, Graham DY. Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7days. Helicobacter 2011; 16: 139-145.
35. Chuah SK, Tsay FW, Hsu PI, Wu DC. A new look at anti-Helicobacter pylori therapy. World J. Gastroenterol. 2011; 17: 3971-3975.